Therapeutic targeting of chemokine signaling in Multiple Sclerosis

Journal of the Neurological Sciences
Isabell HamannCarmen Infante-Duarte

Abstract

Multiple Sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that is initiated and maintained by continuous migration of inflammatory immune cells from the periphery into the target organ. However, in autoimmunity, migration of immune cells is not only involved in the pathogenesis but also in the down-modulation of the autoimmune attack, which is probably mediated by the infiltration of certain regulatory immune cell populations inside the affected organs. The migratory activity of both proinflammatory and regulatory leucocytes is controlled by chemokines and their receptors. Thus, targeting the directed migration of immune cells and regulating leukocyte trafficking across the blood-brain barrier (BBB) by means of modulation of chemokine signaling receptors might open up new therapeutic avenues not only for MS but also for other autoimmune diseases. In this review we summarize the chemotactic signaling pathways known to be involved in neuroinflammation to date and the viability of these pathways as targets for therapeutic strategies.

References

May 1, 1995·Journal of Neuroimmunology·R GodiskaP W Gray
Feb 13, 1997·Nature·J F BazanT J Schall
Jan 29, 1998·The New England Journal of Medicine·B D TrappL Bö
Sep 2, 1998·Proceedings of the National Academy of Sciences of the United States of America·J K HarrisonL Feng
Dec 9, 1998·FEBS Letters·W J SchwaebleM K Schäfer
Mar 17, 1999·The Journal of Clinical Investigation·T L SørensenR M Ransohoff
Nov 5, 1999·The Journal of Biological Chemistry·A E ProudfootT N Wells
Jun 3, 2000·Annual Review of Immunology·D Rossi, A Zlotnik
Jan 4, 2001·Immunological Reviews·S ArimilliS Mocci
May 9, 2001·The Journal of Clinical Investigation·P FraticelliA Mantovani
May 18, 2001·Brain Research. Developmental Brain Research·D Nguyen, M Stangel
Jul 5, 2001·Neuropathology and Applied Neurobiology·S H GoldbergE Lavi
Jul 18, 2001·Frontiers in Neuroendocrinology·A BajettoG Schettini
Nov 8, 2001·Trends in Immunology·P KivisäkkR M Ransohoff
Feb 28, 2002·Journal of the Neurological Sciences·Elio ScarpiniGuglielmo Scarlato
Jul 6, 2002·Journal of Neuroimmunology·Masaru MatsuiRichard M Ransohoff
Jul 13, 2002·European Journal of Immunology·Shosaku NarumiKouji Matsushima
Dec 11, 2002·Journal of Autoimmunity·Andrzej R GlabinskiRichard M Ransohoff
Jan 28, 2003·The American Journal of Pathology·Corinna TrebstRichard M Ransohoff
Mar 12, 2003·The Journal of Experimental Medicine·Orhan AktasFrauke Zipp
Apr 2, 2003·Journal of Neuroimmunology·Stefan KastenbauerHans-Walter Pfister
Jun 28, 2003·Scandinavian Journal of Immunology·A R GlabinskiR M Ransohoff
Aug 28, 2003·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·P PuthetiH Link
Mar 17, 2004·Journal of Neuroimmunology·Koichi NarikawaYasuto Itoyama
Mar 30, 2004·Biochemical Society Transactions·Z JohnsonC Rommel
May 4, 2004·Annals of Neurology·Pia KivisäkkRichard M Ransohoff
Jul 20, 2004·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·T L SørensenF Sellebjerg
Aug 20, 2004·The British Journal of Ophthalmology·T L SørensenF Sellebjerg
Sep 1, 2004·Cellular Signalling·Martin Oppermann
Sep 24, 2004·Current Drug Targets. Inflammation and Allergy·Diane M MullerJudith M Greer
Feb 15, 2005·Brain Research. Brain Research Reviews·Laetitia CartierKarl-Heinz Krause
Mar 19, 2005·Brain : a Journal of Neurology·Kakuri M OmariCedric S Raine
Aug 9, 2005·Glia·Kakuri M OmariCedric S Raine
Sep 8, 2005·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Carmen Infante-DuarteFrauke Zipp
Nov 29, 2005·Trends in Pharmacological Sciences·Eroboghene E UboguRichard M Ransohoff
Feb 10, 2006·The New England Journal of Medicine·Israel F Charo, Richard M Ransohoff

❮ Previous
Next ❯

Citations

Jun 6, 2012·Cell Research·Changsheng Du, Xin Xie
Jun 18, 2009·Brain : a Journal of Neurology·Alexander MildnerMarco Prinz
Dec 29, 2010·Autoimmune Diseases·Kemal Ugur TufekciKursad Genc
Jun 10, 2008·Expert Opinion on Emerging Drugs·Walter J Lukiw
Jun 23, 2012·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Ahmed H Badawi, Teruna J Siahaan
Jun 18, 2010·Journal of Neuroimmunology·Marco Prinz, Josef Priller
Dec 4, 2012·International Journal of Immunogenetics·H J ParkH-S Kim
Jul 19, 2011·Journal of Cellular and Molecular Medicine·Ilana MandelAriel Miller
Jul 1, 2015·Annals of Clinical and Translational Neurology·Marion SalouDavid A Laplaud
Mar 3, 2012·Journal of Neuroimmunology·Leah M Alabanza, Margaret S Bynoe
Nov 6, 2012·Biological & Pharmaceutical Bulletin·Masayuki OkamotoNobuhide Watanabe
Dec 17, 2009·Multiple Sclerosis : Clinical and Laboratory Research·J MellergårdC Dahle
Nov 28, 2015·The EMBO Journal·Magdalena PaterkaFrauke Zipp

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

Astrocytes

Astrocytes are glial cells that support the blood-brain barrier, facilitate neurotransmission, provide nutrients to neurons, and help repair damaged nervous tissues. Here is the latest research.

Blood Brain Barrier & Cytokines

Some cytokines are able to cross the blood brain barrier through transport systems and enter the cerebrospinal fluid and interstitial fluid spaces. Here is the latest research on cytokines crossing the blood brain barrier and how this can affect tissues within the CNS.

Astrocytes & Neurodegeneration

Astrocytes are important for the health and function of the central nervous system. When these cells stop functioning properly, either through gain of function or loss of homeostatic controls, neurodegenerative diseases can occur. Here is the latest research on astrocytes and neurodegeneration.

Cancer Biology: Molecular Imaging

Molecular imaging enables noninvasive imaging of key molecules that are crucial to tumor biology. Discover the latest research in molecular imaging in cancer biology in this feed.

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.